苯巴那酯不同版本一盒的最新价格公布

Phenobarnate is a targeted treatment drug for specific types of epileptic seizures. It was developed by Italian company ANGELINI and was approved by the US FDA in 2019. For patients who require long-term medication, it is crucial to understand the latest prices, domestic availability and treatment effects of drugs. This article will introduce in detail the latest market prices of various specifications of Phenobarate, domestic access methods, and its clinical effects in the treatment of epilepsy.

The latest price of a box of different versions of Phenobarate

The market price varies depending on the specifications and packaging quantity. Understanding the specific price information can help patients make a budget for treatment.

12.5mg+25mg composite packaging

The reference price of the 28-capsule composite specification (12.5mg+25mg) is US$206 per box. This composite packaging is suitable for use in the initial dose adjustment stage.

Price of 50mg specification

The 50mg specification comes in three packages: 14 capsules/box priced at US$117, 28 capsules/box priced at approximately US$231, and 84 capsules/box priced at approximately US$521. The large package of 84 tablets is more cost-effective and suitable for patients taking medicine for a long time.

200mg high-dose specification

The price of 200mg*84 capsules/box is the same as that of 50mg*84 capsules/box, about US$521/box. The high-dose specification is suitable for stable patients who have completed dose adjustment.

Prices may fluctuate due to exchange rate fluctuations and procurement channels. It is recommended to obtain the latest quotations through formal cross-border medical platforms.

Phenobanate’s domestic marketing status

The current domestic marketing status of Phenobarate directly affects patients’ access and treatment options.

Domestic Approval Status

As of now, Phenobarate has not been approved for marketing by the China National Medical Products Administration, nor has it been included in the scope of medical insurance reimbursement. Domestic patients cannot purchase it through conventional channels.

Legal access methods

Patients can obtain it in two legal ways: one is to purchase it through formal cross-border medical service institutions; the other is to use it with a prescription issued by a doctor at a medical institution with overseas drug use qualifications.

Situation of generic drugs

At present, there are no generic drugs of Phenobarate in the domestic market. Patients should be wary of illegal drugs claiming to be "domestic generics" and avoid using drugs of unknown origin.

When purchasing, complete drug import documents and original packaging should be requested to ensure reliable drug quality.

Effectiveness of Phenobarate

Phenobarate has unique pharmacological effects and clinical effects in the treatment of epilepsy, and its efficacy is mainly reflected in the following aspects.

Control epileptic seizures

Clinical data show that phebanate can reduce the frequency of partial epileptic seizures. During the maintenance treatment period, the patient's seizure frequency is reduced.

Targeted mechanism of action

As a GABAA receptor modulator, phenobanamate stabilizes neuronal excitability by enhancing the neuroinhibitory effect mediated by γ-aminobutyric acid, thereby reducing abnormal discharges and epileptic seizures.

Convenience of medication

The once-daily dosing regimen greatly improves medication compliance. The drug can be taken as an oral tablet or made into a suspension, providing convenience for patients with dysphagia.

Efficacy evaluation needs to be combined with electroencephalogram examination and seizure frequency records. It is recommended to conduct a comprehensive evaluation every 3 months. If serious adverse reactions occur, you should seek medical treatment immediately to adjust the plan.